MIRA PHARMACEUTICALS, INC. (MIRA) Reports Material Event to SEC
Filing Details MIRA PHARMACEUTICALS, INC. (NASDAQ:MIRA) filed a Form 8-K with the Securities and Exchange Commission on June 25, 2026, disclosing a material event. Market Context…
Read more
